Osmosun SA
Osmosun S.A. provides water treatment solutions with the use of renewable energy in France. The company offers OSMOSUN that provides sea and brackish water, reverse osmosis desalination units; OSMO-WATT, a containerized solar powered solution for seawater and brackish water desalination; OSMOSUN TAPS, an integrated drinking water production solution for remote areas; and OSMOSUN NOMAD, a water tr… Read more
Osmosun SA (ALWTR) - Net Assets
Latest net assets as of June 2025: €-4.72K EUR
Based on the latest financial reports, Osmosun SA (ALWTR) has net assets worth €-4.72K EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.83 Million) and total liabilities (€2.84 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-4.72K |
| % of Total Assets | -0.17% |
| Annual Growth Rate | -2.29% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 454.57 |
Osmosun SA - Net Assets Trend (2021–2024)
This chart illustrates how Osmosun SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Osmosun SA (2021–2024)
The table below shows the annual net assets of Osmosun SA from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.21 Million | -85.07% |
| 2023-12-31 | €8.13 Million | +902.06% |
| 2022-12-31 | €811.40K | -37.65% |
| 2021-12-31 | €1.30 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Osmosun SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 709468765.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €898.17K | 73.98% |
| Other Components | €10.37 Million | 853.98% |
| Total Equity | €1.21 Million | 100.00% |
Osmosun SA Competitors by Market Cap
The table below lists competitors of Osmosun SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
RespireRx Pharmaceuticals Inc
PINK:RSPI
|
$819.01K |
|
ATOSS SOFTWARE - Dusseldorf Stock Exchang
DU:AOF
|
$819.77K |
|
Identillect Technologies Corp
V:ID
|
$819.87K |
|
E2Gold Inc
OTCQB:ETUGF
|
$819.94K |
|
TTM TECHNOLOGIES - Dusseldorf Stock Exchang
DU:TT1
|
$817.97K |
|
Digitalist Group Oyj
HE:DIGIGR
|
$817.05K |
|
CORP. FIN. ALBA
MU:CSV
|
$817.00K |
|
STARBUCKS (SRB.SG)
STU:SRB
|
$816.91K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Osmosun SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,559,188 to 1,214,131, a change of -6,345,057 (-83.9%).
- Net loss of 6,328,306 reduced equity.
- Other comprehensive income increased equity by 3,360,548.
- Other factors decreased equity by 3,377,299.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-6.33 Million | -521.22% |
| Other Comprehensive Income | €3.36 Million | +276.79% |
| Other Changes | €-3.38 Million | -278.17% |
| Total Change | €- | -83.94% |
Book Value vs Market Value Analysis
This analysis compares Osmosun SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.17x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 2.97x to 3.17x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.23 | €0.69 | x |
| 2022-12-31 | €0.14 | €0.69 | x |
| 2023-12-31 | €1.35 | €0.69 | x |
| 2024-12-31 | €0.22 | €0.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Osmosun SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -521.22%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -337.71%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 4.10x
- Recent ROE (-521.22%) is below the historical average (-154.93%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -17.28% | -11.17% | 0.30x | 5.21x | €-355.03K |
| 2022 | -40.60% | -7.16% | 0.88x | 6.48x | €-410.54K |
| 2023 | -40.62% | -102.27% | 0.25x | 1.62x | €-3.83 Million |
| 2024 | -521.22% | -337.71% | 0.38x | 4.10x | €-6.45 Million |
Industry Comparison
This section compares Osmosun SA's net assets metrics with peer companies in the Pollution & Treatment Controls industry.
Industry Context
- Industry: Pollution & Treatment Controls
- Average net assets among peers: $16,164,982
- Average return on equity (ROE) among peers: 5.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Osmosun SA (ALWTR) | €-4.72K | -17.28% | N/A | $818.09K |
| BIO UV Group (ALTUV) | $30.70 Million | 2.25% | 1.64x | $18.19 Million |
| UV Germi SA (ALUVI) | $1.63 Million | 8.26% | 0.48x | $3.30 Million |